Infection and contamination control products supplier Tristel says a strong last couple of weeks to the financial year mean that it will do better than expected in the year to June 2012.
Tristel expects its profit to be more than £700,000, compared with a previous forecast of £600,000. There was £600,000 in the bank at the end of June 2012.
All three of the major veterinary distributors are ordering Tristelís Anistel products. These products were formerly sold via the supply agreement with Medichem International, which was terminated earlier this year. The Royal Veterinary College is using Anistel products.
At 32p a share, up 1.5p, Tristel is valued at £12.8m.
The full year figures will be published on 29 October.
Download the latest AIM Journal from http://www.hubinvest.com/AIMPDFJuly2012_34.pdf
© 2022 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.